Assuntos
COVID-19 , Tromboembolia Venosa , Estado Terminal , Humanos , Unidades de Terapia Intensiva , SARS-CoV-2RESUMO
We describe an extremely rare case of mediastinitis superinfected by emerging Achromobacter xylosoxidans. After mitral and aortic valves replacement, the patient first developed a Staphylococcus aureus mediastinitis, and five days after starting adapted antibiotic therapy, superficial pus analysis revealed the presence of Achromobacter xylosoxidans. This superinfection was considered superficial and focus was made on Staphylococcus aureus mediastinitis. Three weeks later, no more Staphylococcus aureus was found in pus samples and the sepsis seemed under control. Unfortunately, blood cultures were again positive for Achromobacter xylosoxidans three weeks later and the patient died from septic shock.
Assuntos
Achromobacter denitrificans/isolamento & purificação , Infecções por Bactérias Gram-Negativas/microbiologia , Mediastinite/microbiologia , Infecções Oportunistas/microbiologia , Choque Séptico/microbiologia , Superinfecção/microbiologia , Achromobacter denitrificans/efeitos dos fármacos , Achromobacter denitrificans/genética , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Valva Aórtica/cirurgia , Evolução Fatal , Infecções por Bactérias Gram-Negativas/sangue , Infecções por Bactérias Gram-Negativas/complicações , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Humanos , Masculino , Mediastinite/sangue , Mediastinite/diagnóstico , Mediastinite/tratamento farmacológico , Valva Mitral/cirurgia , Infecções Oportunistas/sangue , Infecções Oportunistas/complicações , Infecções Oportunistas/tratamento farmacológico , Choque Séptico/sangue , Choque Séptico/complicações , Choque Séptico/tratamento farmacológico , Infecções Estafilocócicas/sangue , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Superinfecção/sangue , Superinfecção/complicações , Superinfecção/tratamento farmacológico , Supuração/microbiologiaRESUMO
BACKGROUND: Although varicelliform Kaposi eruption is a well-known complication of dermatoses, it has not been widely investigated. AIM: To investigate features of dermatoses and herpes superinfection in patients hospitalized in a dermatology department. PATIENTS AND METHODS: We performed a single-centre, retrospective study between 2008 and 2014 that included cases of Kaposi varicelliform eruptions defined by positive PCR of an unconventional site of herpetic recurrence in a setting of active dermatitis. A record was compiled of each case giving details of the history, clinical and laboratory findings, therapeutic data and outcome. RESULTS: Thirty-four cases of Kaposi varicelliform eruptions in 30 subjects were studied. Mean age at diagnosis was 63.3±24.2 years. The underlying dermatoses were as follows: 7 pemphigus, 6 bullous pemphigoid, 3 cicatricial pemphigoid, 3 atopic dermatitis, 1 Darier disease, and 14 other dermatoses. Patients presented with skin (94.1 %) or mucous membrane lesions (62 %), mostly erosive (79 %), vesicular (27 %) or bullous (41 %), often painful (56 %) or pruritic (29 %). At diagnosis, 41.2 % were undergoing systemic immunotherapy and 24 % were on topical corticosteroids. PCR was positive for HSV1 in 20 cases and for HSV2 in 4 cases, and indeterminate in 10 cases. Lymphocytopenia was seen in 59 % of cases. The majority of patients received treatment. Nine patients experienced at least one relapse. CONCLUSION: Our study confirms the over-representation not only of the expected dermatoses (pemphigus and atopic dermatitis), but also of others such as pemphigoid and acute dermatoses; these results should be investigated in a more systematic prospective study.
Assuntos
Hospedeiro Imunocomprometido , Pacientes Internados , Erupção Variceliforme de Kaposi/diagnóstico , Dermatopatias/diagnóstico , Superinfecção , Administração Cutânea , Adulto , Idoso , Idoso de 80 Anos ou mais , Antivirais/administração & dosagem , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Glucocorticoides/administração & dosagem , Humanos , Erupção Variceliforme de Kaposi/complicações , Erupção Variceliforme de Kaposi/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Dermatopatias/complicações , Dermatopatias/tratamento farmacológico , Resultado do TratamentoRESUMO
OBJECTIVE: Dengue virus consists of four antigenically distinct serotypes (DENV 1-4) that are transmitted to humans by Aedes aegypti and Aedes albopictus mosquitoes. In many dengue-endemic regions, co-circulation of two or more DENV serotypes is fairly common increasing the likelihood for exposure of the two vectors to multiple serotypes. We used a model system of DENV-2 and DENV-4 to investigate how prior exposure of Aedes aegypti to one DENV serotype affects its susceptibility to another serotype. METHODS: Aedes aegypti mosquitoes were sequentially infected with DENV-2 and DENV-4 and the infection and dissemination rates for each virus determined. RESULTS: We found that prior infection of Ae. aegypti mosquitoes with DENV-4 rendered them significantly less susceptible to secondary infection with DENV-2. Although the results were not statistically significant, mosquitoes infected with DENV-2 were also less susceptible to secondary infection with DENV-4. The midgut dissemination and population dissemination rates for DENV-2 were significantly higher than those of DENV-4 when either virus was administered 7 days after administration of either a non-infectious blood meal or a blood meal containing a heterologous dengue serotype. CONCLUSION: These results demonstrate that superinfection interference between DENV serotypes is possible within Ae. aegypti mosquitoes, but its effect on DENV epidemiology may be dependent on the fitness of interacting serotypes.